BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9523920)

  • 1. Intracerebroventricular cholecystokinin A-receptor antagonist does not reduce satiation by endogenous CCK.
    Brenner LA; Ritter RC
    Physiol Behav; 1998 Feb; 63(4):711-6. PubMed ID: 9523920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type A CCK receptors mediate satiety effects of intestinal nutrients.
    Brenner LA; Ritter RC
    Pharmacol Biochem Behav; 1996 Jul; 54(3):625-31. PubMed ID: 8743639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK-receptor antagonists attenuate suppression of sham feeding by intestinal nutrients.
    Yox DP; Brenner L; Ritter RC
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R554-61. PubMed ID: 1373576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of centrally administered CCK-receptor antagonists on food intake in rats.
    Corp ES; Curcio M; Gibbs J; Smith GP
    Physiol Behav; 1997 Jun; 61(6):823-7. PubMed ID: 9177553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
    Ebenezer IS; Baldwin BA
    Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracerebroventricular administration of the CCK(1) receptor antagonist devazepide on food intake in rats.
    Ebenezer IS
    Eur J Pharmacol; 2002 Apr; 441(1-2):79-82. PubMed ID: 12007923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
    Lu L; Zhang B; Liu Z; Zhang Z
    Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist.
    Dynes RA; Poppi DP; Barrell GK; Sykes AR
    Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devazepide, a CCK(A) antagonist, attenuates the satiating but not the preference conditioning effects of intestinal carbohydrate infusions in rats.
    Pérez C; Lucas F; Sclafani A
    Pharmacol Biochem Behav; 1998 Feb; 59(2):451-7. PubMed ID: 9476995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent effects of CCK and devazepide in male and female rats.
    Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
    Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a cholecystokinin-A receptor blocker on protein-induced food intake suppression in rats.
    Trigazis L; Orttmann A; Anderson GH
    Am J Physiol; 1997 Jun; 272(6 Pt 2):R1826-33. PubMed ID: 9227596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCK is involved in both peripheral and central mechanisms controlling food intake in chickens.
    Rodríguez-Sinovas A; Fernández E; Manteca X; Fernández AG; Goñalons E
    Am J Physiol; 1997 Jan; 272(1 Pt 2):R334-40. PubMed ID: 9039026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat.
    Francis J; Dourish CT; Cooper SJ
    Physiol Behav; 1996 Nov; 60(5):1337-40. PubMed ID: 8916191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the CCK receptor antagonist MK-329 on food intake in broiler chickens.
    Covasa M; Forbes JM
    Pharmacol Biochem Behav; 1994 Jun; 48(2):479-86. PubMed ID: 8090818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
    Woltman T; Reidelberger R
    Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Devazepide antagonizes the inhibitory effect of cholecystokinin on intake in sham-feeding rats.
    Melville LD; Smith GP; Gibbs J
    Pharmacol Biochem Behav; 1992 Nov; 43(3):975-7. PubMed ID: 1448494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BIM-18216, a novel cholecystokinin receptor antagonist, on food intake reduction induced by cholecystokinin.
    Laferrere B; Nguyen M; Bonhomme G; Legall A; Basdevant A; Guy-Grand B
    Behav Neurosci; 1991 Oct; 105(5):707-11. PubMed ID: 1815620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-A receptor mediation of food intake in cats.
    Bado A; Durieux C; Moizo L; Roques BP; Lewin MJ
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R693-7. PubMed ID: 2012242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.